PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3512249

Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.

M G Angelos·G C Hamilton
View original source ↗Export metadata ↓

Abstract

Three coagulation tests available in the emergency department are described in this article. Methods, results, and implications in the bleeding patient are reviewed.

Explore related subjects

Bleeding TimeBlood CoagulationBlood Coagulation DisordersBlood Coagulation FactorsBlood Coagulation TestsBlood Platelet DisordersBlood PlateletsBlood Specimen CollectionDiagnosis, DifferentialDisseminated Intravascular CoagulationEmergenciesFactor XIII DeficiencyFibrinolysisHemorrhageHemostasisHumansPartial Thromboplastin TimeProthrombin TimeJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M G Angelos, G C Hamilton. 1986. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.. https://pubmed.ncbi.nlm.nih.gov/3512249/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor.

We characterized the cause of two cases of transitory acquired von Willebrand syndrome associated with the administration of ciprofloxacin. Purified Ig from the two patients did not inhibit Ristocetin Cofactor activity or binding to collagen of normal plasma, ruling out the possibility of an inhibitor. The analysis of multimeric pattern of plasma von Willebrand Factor (vWF) showed the lack of larger multimers in both patients, with a relative decrease of all the remaining forms in the first patient. The subunit composition of plasma vWF showed a marked reduction of the native 225 Kd subunit (31.9% and 32.9%; normal range 74-86%) and an increased proportion of the 189, 176, and 140 Kd fragments. These abnormalities disappeared during the follow-up, without any specific therapy. In conclusion, a common pathophysiological basis is demonstrated in both patients, with a heightened proteolysis of plasma vWF by an unknown mechanism.

Bleeding Time↗
PubMed1995

Hematological parameters influencing the Thrombostat 4000.

The effects of platelet counts, hematocrit, and leukocyte counts were studied on the closure times of the Thrombostat 4000 (in-vitro bleeding time, IVBT). Closure times became longer with platelet counts < 50 x 10(9)/L; an inverse linear correlation could be established. Hematocrit was also inversely correlated with the closure time. At constant platelet counts a hematocrit of 55% yielded an immediate closure of the filter, while with a hematocrit < 15% no closure times could be measured. At constant platelet counts and hematocrits, nomonuclear and polymorphonuclear leukocytes also influenced closure times; increased counts resulted in shorter closure times. Leukocytes from a patient with chronic myelocytic leukemia had the same effects.

Bleeding Time↗